Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Development of an internally controlled antibody microarray.

Eric W Olle1, Arun Sreekumar, Roscoe L Warner

  • 1Pfizer Global Research and Development, Ann Arbor, Michigan 48105, USA.

Molecular & Cellular Proteomics : MCP
|July 26, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>TERT</i> Promoter Mutations in Keratinizing and Nonkeratinizing Squamous Metaplasia of the Urinary Tract.

European urology open science·2022
Same author

Biochemical characterization of the interaction between KRAS and Argonaute 2.

Biochemistry and biophysics reports·2022
Same author

Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer.

Nature·2021
Same author

Urinary MyProstateScore (MPS) to Rule out Clinically-Significant Cancer in Men with Equivocal (PI-RADS 3) Multiparametric MRI: Addressing an Unmet Clinical Need.

Urology·2021
Same author

G3BP1 inhibits Cul3<sup>SPOP</sup> to amplify AR signaling and promote prostate cancer.

Nature communications·2021
Same author

Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer.

European urology oncology·2021

A novel single-antibody microarray standardizes protein detection by normalizing antibody quantity, improving sensitivity and reducing variability compared to traditional methods. This high-throughput technology shows promise for complex biofluid analysis.

Area of Science:

  • Biotechnology
  • Proteomics
  • Assay Development

Background:

  • Antibody microarrays are essential for high-throughput protein expression screening.
  • Current ELISA-based arrays use two antibodies and require careful normalization of antibody amounts.
  • Antigen-antibody interactions are concentration-dependent, necessitating precise control.

Purpose of the Study:

  • To develop an improved antibody microarray for protein expression screening.
  • To address limitations of existing two-antibody systems.
  • To create a standardized, high-throughput protein detection method.

Main Methods:

  • Developed a single-antibody microarray system.
  • Utilized antibody spot quantity for antigen standardization.

Related Experiment Videos

  • Implemented an internally controlled system with dual-color detection for antibody and antigen levels.
  • Validated the array with cytokine proteins and mouse macrophage cell lysates.
  • Compared results with Western blot analysis.

    • Main Results:

    • Normalization for antibody spot intensity reduced variability and lowered detection limits compared to median fluorescence intensity alone.
    • The new antibody array demonstrated comparable sensitivity to Western blot analysis, with some assays showing higher sensitivity.
    • Successfully evaluated the expression of interleukin (IL)-1beta, IL-5, IL-6, and macrophage inflammatory proteins 1alpha and 1beta.

    Conclusions:

    • A novel single-antibody microarray has been developed for protein expression screening.
    • This array offers improved standardization and sensitivity over existing methods.
    • The technology is scalable for high-throughput screening of hundreds of proteins in complex biofluids.